Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had little to do with killing cancer cells and everything to do with reaching them. The brain’s protective blood-brain barrier (BBB) blocks […]This is a curated summary.